Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


Articles published in Eur Radiol

Retrieve available abstracts of 25 articles:
HTML format
Text format



Single Articles


    September 2018
  1. BOTSIKAS D, Bagetakos I, Picarra M, Da Cunha Afonso Barisits AC, et al
    What is the diagnostic performance of 18-FDG-PET/MR compared to PET/CT for the N- and M- staging of breast cancer?
    Eur Radiol. 2018 Sep 28. pii: 10.1007/s00330-018-5720.
    PubMed     Text format     Abstract available


  2. TARON J, Fleischer S, Preibsch H, Nikolaou K, et al
    Background parenchymal enhancement in pregnancy-associated breast cancer: a hindrance to diagnosis?
    Eur Radiol. 2018 Sep 18. pii: 10.1007/s00330-018-5721.
    PubMed     Text format     Abstract available


    August 2018
  3. JOUKAINEN S, Masarwah A, Kononen M, Husso M, et al
    Feasibility of mapping breast cancer with supine breast MRI in patients scheduled for oncoplastic surgery.
    Eur Radiol. 2018 Aug 17. pii: 10.1007/s00330-018-5681.
    PubMed     Text format     Abstract available


  4. SUO S, Zhang D, Cheng F, Cao M, et al
    Added value of mean and entropy of apparent diffusion coefficient values for evaluating histologic phenotypes of invasive ductal breast cancer with MR imaging.
    Eur Radiol. 2018 Aug 16. pii: 10.1007/s00330-018-5667.
    PubMed     Text format     Abstract available


  5. ROSSI F, Valdora F, Barabino E, Calabrese M, et al
    Muscle mass estimation on breast magnetic resonance imaging in breast cancer patients: comparison between psoas muscle area on computer tomography and pectoralis muscle area on MRI.
    Eur Radiol. 2018 Aug 7. pii: 10.1007/s00330-018-5663.
    PubMed     Text format     Abstract available


    July 2018
  6. VAN ZELST JCM, Tan T, Clauser P, Domingo A, et al
    Dedicated computer-aided detection software for automated 3D breast ultrasound; an efficient tool for the radiologist in supplemental screening of women with dense breasts.
    Eur Radiol. 2018;28:2996-3006.
    PubMed     Text format     Abstract available


    June 2018
  7. MATHIEU MC, Toullec A, Benoit C, Berry R, et al
    Preclinical ex vivo evaluation of the diagnostic performance of a new device for in situ label-free fluorescence spectral analysis of breast masses.
    Eur Radiol. 2018;28:2507-2515.
    PubMed     Text format     Abstract available


  8. SCHAEFGEN B, Heil J, Barr RG, Radicke M, et al
    Initial results of the FUSION-X-US prototype combining 3D automated breast ultrasound and digital breast tomosynthesis.
    Eur Radiol. 2018;28:2499-2506.
    PubMed     Text format     Abstract available


  9. HU Y, Yang Y, Gu R, Jin L, et al
    Does patient age affect the PPV3 of ACR BI-RADS Ultrasound categories 4 and 5 in the diagnostic setting?
    Eur Radiol. 2018;28:2492-2498.
    PubMed     Text format     Abstract available


  10. ROMERO MARTIN S, Raya Povedano JL, Cara Garcia M, Santos Romero AL, et al
    Prospective study aiming to compare 2D mammography and tomosynthesis + synthesized mammography in terms of cancer detection and recall. From double reading of 2D mammography to single reading of tomosynthesis.
    Eur Radiol. 2018;28:2484-2491.
    PubMed     Text format     Abstract available


    May 2018
  11. MALL S, Noakes J, Kossoff M, Lee W, et al
    Can digital breast tomosynthesis perform better than standard digital mammography work-up in breast cancer assessment clinic?
    Eur Radiol. 2018 May 30. pii: 10.1007/s00330-018-5473.
    PubMed     Text format     Abstract available


  12. CHEN BB, Lu YS, Yu CW, Lin CH, et al
    Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancer.
    Eur Radiol. 2018 May 16. pii: 10.1007/s00330-018-5448.
    PubMed     Text format     Abstract available


  13. VAN DER VELDEN BHM, Sutton EJ, Carbonaro LA, Pijnappel RM, et al
    Contralateral parenchymal enhancement on dynamic contrast-enhanced MRI reproduces as a biomarker of survival in ER-positive/HER2-negative breast cancer patients.
    Eur Radiol. 2018 May 7. pii: 10.1007/s00330-018-5470.
    PubMed     Text format     Abstract available


  14. WATANABE G, Itoh M, Duan X, Watabe H, et al
    (18)F-fluorodeoxyglucose specimen-positron emission mammography delineates tumour extension in breast-conserving surgery: Preliminary results.
    Eur Radiol. 2018;28:1929-1937.
    PubMed     Text format     Abstract available


    April 2018
  15. KIM JY, Kim JJ, Kim S, Choo KS, et al
    Diffusion tensor magnetic resonance imaging of breast cancer: associations between diffusion metrics and histological prognostic factors.
    Eur Radiol. 2018 Apr 30. pii: 10.1007/s00330-018-5429.
    PubMed     Text format     Abstract available


  16. KIM WH, Cho N, Kim YS, Yi A, et al
    Mammographic density changes following discontinuation of tamoxifen in premenopausal women with oestrogen receptor-positive breast cancer.
    Eur Radiol. 2018 Apr 6. pii: 10.1007/s00330-017-5293.
    PubMed     Text format     Abstract available


    March 2018
  17. SANABRIA SJ, Goksel O, Martini K, Forte S, et al
    Breast-density assessment with hand-held ultrasound: A novel biomarker to assess breast cancer risk and to tailor screening?
    Eur Radiol. 2018 Mar 19. pii: 10.1007/s00330-017-5287.
    PubMed     Text format     Abstract available


  18. KIM SY, Shin J, Kim DH, Kim EK, et al
    Correlation between electrical conductivity and apparent diffusion coefficient in breast cancer: effect of necrosis on magnetic resonance imaging.
    Eur Radiol. 2018 Mar 6. pii: 10.1007/s00330-017-5291.
    PubMed     Text format     Abstract available


    January 2018
  19. KIM SY, Cho N, Shin SU, Lee HB, et al
    Contrast-enhanced MRI after neoadjuvant chemotherapy of breast cancer: lesion-to-background parenchymal signal enhancement ratio for discriminating pathological complete response from minimal residual tumour.
    Eur Radiol. 2018 Jan 29. pii: 10.1007/s00330-017-5251.
    PubMed     Text format     Abstract available


  20. LI X, Gao H, Chen Z, Zhang L, et al
    Diagnosis of breast cancer based on microcalcifications using grating-based phase contrast CT.
    Eur Radiol. 2018 Jan 26. pii: 10.1007/s00330-017-5158.
    PubMed     Text format     Abstract available


  21. HORVAT JV, Durando M, Milans S, Patil S, et al
    Apparent diffusion coefficient mapping using diffusion-weighted MRI: impact of background parenchymal enhancement, amount of fibroglandular tissue and menopausal status on breast cancer diagnosis.
    Eur Radiol. 2018 Jan 12. pii: 10.1007/s00330-017-5202.
    PubMed     Text format     Abstract available


    December 2017
  22. RODRIGUEZ-RUIZ A, Gubern-Merida A, Imhof-Tas M, Lardenoije S, et al
    One-view digital breast tomosynthesis as a stand-alone modality for breast cancer detection: do we need more?
    Eur Radiol. 2017 Dec 11. pii: 10.1007/s00330-017-5167.
    PubMed     Text format     Abstract available


    November 2017
  23. MOSHINA N, Roman M, Waade GG, Sebuodegard S, et al
    Breast compression parameters and mammographic density in the Norwegian Breast Cancer Screening Programme.
    Eur Radiol. 2017 Nov 2. doi: 10.1007/s00330-017-5104.
    PubMed     Text format     Abstract available


    October 2017
  24. ZHAO J, Zhang J, Zhu QL, Jiang YX, et al
    The value of contrast-enhanced ultrasound for sentinel lymph node identification and characterisation in pre-operative breast cancer patients: A prospective study.
    Eur Radiol. 2017 Oct 20. doi: 10.1007/s00330-017-5089.
    PubMed     Text format     Abstract available


  25. GIROMETTI R, Zanotel M, Londero V, Linda A, et al
    Automated breast volume scanner (ABVS) in assessing breast cancer size: A comparison with conventional ultrasound and magnetic resonance imaging.
    Eur Radiol. 2017 Oct 10. doi: 10.1007/s00330-017-5074.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: